Compound Q&A
What is the market or research trend for Treprostinil (CAS: 81846-19-7)?
Answer
The market for Treprostinil (CAS: 81846-19-7) is focused on its use as a vasodilator in the treatment of pulmonary arterial hypertension. Research trends include the development of its prodrug forms, such as selexipag, and the exploration of new formulations to improve patient compliance and efficacy. Additionally, there is ongoing interest in understanding the mechanisms of action and identifying potential off-label applications.
About
CAS No
81846-19-7
English Name
Treprostinil
Molecular Formula
C23H34O5
Molecular Weight
390.52 g/mol
SMILES
CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2Cc3c(OCC(=O)O)cccc3C[C@H]12
InChIKey
PAJMKGZZBBTTOY-ZFORQUDYSA-N
Last Updated: 2025-10-06 07:30
